Masimo Corporation (MASI) is a publicly traded company in the Healthcare sector, operating within the Medical - Instruments & Supplies industry. The company is headquartered in Irvine, CA, United States. The current CEO is Catherine Szyman.
MASI has IPO date of 2007-08-08, 3,600 full-time employees, listed on the NASDAQ Global Select, a market capitalization of $9.34B.
Masimo Corporation is a global medical technology company that develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions. The company's core offerings include advanced pulse oximetry systems with its proprietary signal extraction technology, the Masimo rainbow SET platform for comprehensive hemoglobin monitoring, brain function monitoring via SedLine, capnography and gas monitoring products, and regional tissue oximetry solutions. Additionally, Masimo provides its Hospital Automation platform featuring patient safety and surveillance systems, along with connectivity devices and ventilation solutions. The company serves hospitals, emergency medical services, home care providers, long-term care facilities, and consumers through direct sales, distributors, and original equipment manufacturer partnerships. Founded in 1989 and headquartered in Irvine, California, Masimo has established itself as a leader in patient monitoring and clinical automation technologies.
